Zhejiang Medicine Co Ltd (600216):企業の財務・戦略的SWOT分析

◆英語タイトル:Zhejiang Medicine Co Ltd (600216) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12936
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Zhejiang Medicine Co Ltd (600216) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zhejiang Medicine Co Ltd (Zhejiang Medicine) develops, manufactures and markets biological drugs, pharmaceutical intermediates and bio-pesticides. The company’s product portfolio consists of animal nutrition, active pharmaceutical ingredients (APls) and intermediates; antibiotics and human nutrition products including vitamin E, natural vitamin E, vitamin A, vitamin H, vitamin D3, coenzyme Q10, beta-carotene, fat-soluble vitamins, carotenoids and other pharmaceutical preparations. The company provides its products in large and small volume injections, freeze dried powder injections, tablets, hard and soft capsules, pills and oral solutions. It has two research and development (R&D) centers, namely, Shaoxing Research Institute of Pharmaceutical Industry and Shanghai Health Creation Biological Drug Research and Development Center. Zhejiang Medicine is headquartered in Shaoxing, Zhejiang, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Zhejiang Medicine Co Ltd – Key Facts 5
Zhejiang Medicine Co Ltd – Key Employees 6
Zhejiang Medicine Co Ltd – Key Employee Biographies 7
Zhejiang Medicine Co Ltd – Key Operational Employees 8
Zhejiang Medicine Co Ltd – Major Products and Services 9
Zhejiang Medicine Co Ltd – History 11
Zhejiang Medicine Co Ltd – Company Statement 13
Zhejiang Medicine Co Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Zhejiang Medicine Co Ltd – Business Description 16
R&D Overview 16
Zhejiang Medicine Co Ltd – Corporate Strategy 17
Zhejiang Medicine Co Ltd – SWOT Analysis 18
SWOT Analysis – Overview 18
Zhejiang Medicine Co Ltd – Strengths 18
Zhejiang Medicine Co Ltd – Weaknesses 19
Zhejiang Medicine Co Ltd – Opportunities 20
Zhejiang Medicine Co Ltd – Threats 21
Zhejiang Medicine Co Ltd – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Financial Performance 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 29
Zhejiang Medicine Co Ltd, Recent Deals Summary 30
Section 5 – Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Zhejiang Medicine Co Ltd, Key Facts 5
Zhejiang Medicine Co Ltd, Key Employees 6
Zhejiang Medicine Co Ltd, Key Employee Biographies 7
Zhejiang Medicine Co Ltd, Key Operational Employees 8
Zhejiang Medicine Co Ltd, Major Products and Services 9
Zhejiang Medicine Co Ltd, History 11
Zhejiang Medicine Co Ltd, Subsidiaries 14
Zhejiang Medicine Co Ltd, Key Competitors 22
Zhejiang Medicine Co Ltd, Ratios based on current share price 23
Zhejiang Medicine Co Ltd, Annual Ratios 24
Zhejiang Medicine Co Ltd, Annual Ratios (Cont...1) 25
Zhejiang Medicine Co Ltd, Annual Ratios (Cont...2) 26
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 29
Zhejiang Medicine Co Ltd, Recent Deals Summary 30
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 33
Efficiency Ratios 34

List of Figures
Zhejiang Medicine Co Ltd, Ratio Charts 27
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 29

★海外企業調査レポート[Zhejiang Medicine Co Ltd (600216):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Louisville-製薬・医療分野:企業M&A・提携分析
    Summary University of Louisville (UofL) is an educational university that offers undergraduate, graduate, post-baccalaureate pre-med program, dentistry, law and online programs. The university offers courses such as accountancy, aerospace studies, art education, bioengineering, business administrati …
  • POET Technologies Inc (PTK):企業の財務・戦略的SWOT分析
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company offers products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among o …
  • Lassonde Industries Inc.:企業の戦略・SWOT・財務情報
    Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Riken Vitamin Co Ltd:企業の戦略・SWOT・財務情報
    Riken Vitamin Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Riken Vitamin Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Harmonic Inc (HLIT):企業の財務・戦略的SWOT分析
    Harmonic Inc (HLIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bio-Alternative Medical Devices Ltd:企業の製品パイプライン分析2018
    Summary Bio-Alternative Medical Devices Ltd (Bio AMD), a subsidiary of Bio-AMD Inc, is a medical device company that designs, develops, and markets point of care medical diagnostic products. The company offers products such as blood coagulation monitor, digital strip reader, and magnetic immunoassay …
  • Lixil Group Corporation (5938):企業の財務・戦略的SWOT分析
    Lixil Group Corporation (5938) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Respiratory Motion Inc:医療機器:M&Aディール及び事業提携情報
    Summary Respiratory Motion Inc (Respiratory Motion) is a medical device company with focus on the development and commercialization of non-invasive monitoring devices for respiratory function. The company developed ExSpiron 1Xi, a next generation respiratory monitoring system that provides non-invas …
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • MiMedx Group Inc (MDXG)-医療機器分野:企業M&A・提携分析
    Summary MiMedx Group Inc (MiMedx) is a provider of bioactive healing products for tissue regeneration. The company’s products are used in the therapeutic areas of chronic wounds, dental, ophthalmology, spine, orthopedic surgery, sports medicine and urology. Its products help in reducing inflammation …
  • Dubai Electricity and Water Authority-エネルギー分野:企業M&A・提携分析
    Summary Dubai Electricity and Water Authority (DEWA) generates, transmits and distributes electricity; and conducts desalination of water. DEWA’s power plants included Jebel Ali Power Station D, E, G, K, L Phase I, L Phase II, and M; Aweer Power Station H Phase I, Phase II, and Phase III. The desali …
  • Monster Worldwide Inc:企業の戦略的SWOT分析
    Monster Worldwide Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Perpetual Energy Inc. (PMT)-石油・ガス分野:企業M&A・提携分析
    Summary Perpetual Energy Inc. (Perpetual Energy) is an exploration and production company. It explores, develops and produces from shallow gas, liquids-rich gas, heavy oil, bitumen and other assets. The company produces light and medium crude oil, heavy oil natural gas and natural gas liquids. Perpe …
  • Delaware Electric Cooperative Inc:企業の戦略的SWOT分析
    Delaware Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • IDL Biotech AB (IDL B):企業の財務・戦略的SWOT分析
    Summary IDL Biotech AB (IDL Biotech) is a biotechnology company that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include b …
  • Matrix Service Co:企業の戦略・SWOT・財務分析
    Matrix Service Co - Strategy, SWOT and Corporate Finance Report Summary Matrix Service Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Holder Construction Co:企業の戦略的SWOT分析
    Holder Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PositiveID Corp (PSID)-医療機器分野:企業M&A・提携分析
    Summary PositiveID Corp (PositiveID) is a medical device company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products include firefly Dx and m-band. PositiveID’s tec …
  • EnBW Energie Baden-Wuerttenberg AG:企業のM&A・事業提携・投資動向
    EnBW Energie Baden-Wuerttenberg AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnBW Energie Baden-Wuerttenberg AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Telecom Plus plc (TEP):企業の財務・戦略的SWOT分析
    Telecom Plus plc (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆